| |
| Magyar Dermatológiai Társulat |
|
| DAB Immunológiai Munkabizottság allergológiai ülése, Interaktív betegbemutatások |
 Rendezvény kezdete: 2009.02.20. | Rendezvény vége: 2009.02.20. |
| Tudományos információ: Dr. Szegedi Andrea |
| Munkahely neve: Debreceni Egyetem OEC, Bőrgyógyászati Klinika |
| Címe: 4032 Debrecen, Nagyerdei krt. 98. |
| Tel: 52 432-282 |
| Fax: 52 414-632 |
| E-mail: dermatologia@dote.hu; aszegedi@dote.hu |
| Szervező: Dr. Szegedi Andrea |
| Munkahely neve: Debreceni Egyetem OEC, Bőrgyógyászati Klinika |
| Címe: 4032 Debrecen, Nagyerdei krt. 98. |
| Tel: 52 432-282 |
| Fax: 52 414-632 |
| E-mail: dermatologia@dote.hu; aszegedi@dote.hu |
| Helyszín: 4026 Debrecen, Hunyadi út 1-3., Kölcsey Központ |
| A rendezvény Web oldala: http://www.dermatology.dote.hu |
(Immunological study group of the DAB, Allergology Conference, Case reports)
Fő témák: betegbemutatások: angiooedema, Henoch-Schönlein purpura, asthma, COPD, polyangiopathia, vasculitis. |
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
